Oral Abstract Session:
31. Infant Viral Infections
Thursday, October 4, 2018: 8:45 AM-10:00 AM
Room: S 156

Tracks: Investigative ID, Pediatric ID

Moderators:  Evan J. Anderson, MD, Atlanta Veterans Affairs Medical Center and Helen Chu, MD MPH, University of Washington

8:45 AM
Birth Prevalence of Congenital Cytomegalovirus Infection and Language, Hearing and Developmental Outcomes in a Cohort of HIV-Exposed, Uninfected Preschool Children
Murli Purswani, MD; Tzy-Jyun Yao, PhD; Jonathan S. Russell, MPH; Kathleen Malee, PhD; Stephen A. Spector, MD, FIDSA; Paige Williams, PhD; Toni Frederick, PhD; Sandra Burchett, MD, MS; Monika Dietrich, MD; Sean Redmond, PhD; Howard Hoffman, MA; Peter Torre III, PhD; Sonia Lee, PhD; Mabel Rice, PhD
9:00 AM
Results of a Targeted Neonatal Screening Program for Congenital Cytomegalovirus Infection in Montreal, Quebec
Christian Renaud, MD, MSc, FRCPC; Mina Smiljkovic, MD; Isabelle Boucoiran, MD, MSc; Silvie Valois, RN; Bruce Tapiero, MD; Valérie Lamarre, MD; Fatima Kakkar, MD, MPH
9:15 AM
Role of Maternal Antibodies in Protection Against Postnatal Cytomegalovirus Acquisition
Frances Saccoccio, MD, PhD; Hannah Itell, BS; Skukhang Li, BS; Jennifer Jenks, BS; Guan Xie, PhD; Justin Pollara, Phd; Soren Gantt, MD, PhD; Sallie Permar, MD, PhD
9:30 AM
Effect of nasopharyngeal pneumococcal carriage on RSV and hMPV illness severity in infants in Nepal
Alastair Murray, BA; Janet Englund, MD, FIDSA; Jane Kuypers, PhD; James Tielsch, PhD, MA; Joanne Katz, ScD; Laxman Shrestha, MBBS, MD; Subarna Khatry, MBBS, DOMS; Steven C Leclerq, MPH; Mark C. Steinhoff, MD, FIDSA; Helen Y. Chu, MD MPH
9:45 AM
Nasopharyngeal (NP) Bacterial Detection in infants with Respiratory Syncytial Virus (RSV) infection: Impact on Clinical Outcomes
Alejandro Diaz, MD; Eleonora Bunsow, MD PhD; Cristina Garcia-Maurino, MD; Jeffrey Naples, MD; Alexis Juergensen, BA; Sara Mertz, BS; Huanyu Wang, PhD; Douglas Salamon, BS; Amy Leber, PhD; Octavio Ramilo, MD, FPIDS; Asuncion Mejias, MD, PhD, MsCS

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.